The Effect of Standardizing Procedures for SC Injections of LMWH on Patients With CVD
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Active Control, Standardized injection protocol.
- Who it may be relevant to
- Registry conditions: CVD - Cardiovascular Disease, Bruise, Pain. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Hong Kong
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Effect of Standardizing Procedures for Subcutaneous Injections of Low-molecular-weight Heparin on Patients With Cardiovascular Diseases: A Cluster Randomized Controlled Trial
Overview
Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.
Detailed description
This study examines the effect of standardized protocol in reducing complications for patients with cardiovascular disease.
Interventions
- Other Active Control
Patients in the control group will receive the usual practice of subcutaneous LMWH injection administered by nurses. - Other Standardized injection protocol
Nurses administer LMWH according to the standardized evidence-based protocol.
Primary outcome measures
- Bruising [Time frame: 24 hours, 48 hours, 72 hours]
- Pain [Time frame: Immediately after injection, 24 hours, 48 hours, 72 hours]
Secondary outcome measures (2)
- Patient Experience [Time frame: Immediately after receiving the injection]
- Communicative Competence [Time frame: Immediately before and after injection]
Eligibility criteria
Inclusion criteria
- patients who are in cardiac care units suffering from cardiovascular diseases prescribed with LMWH injections two times per day
- Chinese
Exclusion criteria
- cognitively impaired
- unconscious
- refuse to participate
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Triple blind
- Primary purpose
- Treatment
Study locations
Hong Kong · 1 center
- Hospital Authority, Hong Kong — Hong Kong
Identifiers
NCT: NCT06776159 · 20250301 · CHEUNGPuiYu